Churg-Strauss syndrome epidemiology and demographics: Difference between revisions
(→Age) |
No edit summary |
||
Line 2: | Line 2: | ||
{{Churg-Strauss syndrome}} | {{Churg-Strauss syndrome}} | ||
{{CMG}}{{APM}}{{AE}}{{ | {{CMG}}{{APM}}{{AE}}{{CK}} | ||
==Overview== | ==Overview== | ||
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.<ref name="pmid14872461" /> | The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.<ref name="pmid14872461" /> | ||
Line 18: | Line 18: | ||
===Race=== | ===Race=== | ||
In general, there is no racial | In general, there is no racial predominance to [[eosinophilic granulomatosis with polyangiitis]]. | ||
==References== | ==References== |
Revision as of 19:37, 3 April 2018
Churg-Strauss syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Churg-Strauss syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Churg-Strauss syndrome epidemiology and demographics |
Churg-Strauss syndrome epidemiology and demographics in the news |
Blogs on Churg-Strauss syndrome epidemiology and demographics |
Risk calculators and risk factors for Churg-Strauss syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Ali Poyan Mehr, M.D. [2]Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [3]
Overview
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year, with higher prevalences seen in Europeans.[1]
Epidemiology and Demographics
Prevalence
The prevalence of Eosinophilic granulomatosis with polyangiitis ranges from 2 to 13 per million persons per year.[1][2]
Incidence
The incidence of Eosinophilic granulomatosis with polyangiitis range from 0.5 to 6.8 per million persons per year.[3]
Demographics
Age
The mean age at diagnosis of eosinophilic granulomatosis with polyangiitis is around 45-50 years.
Gender
In general, there is no gender predilection to Eosinophilic granulomatosis with polyangiitis in western nations. In Japan, female predominance has been noted.[4]
Race
In general, there is no racial predominance to eosinophilic granulomatosis with polyangiitis.
References
- ↑ 1.0 1.1 Mahr A, Guillevin L, Poissonnet M, Aymé S (2004). "Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate". Arthritis Rheum. 51 (1): 92–9. doi:10.1002/art.20077. PMID 14872461.
- ↑ Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
- ↑ Gioffredi A, Maritati F, Oliva E, Buzio C (2014). "Eosinophilic granulomatosis with polyangiitis: an overview". Front Immunol. 5 ( ): 549. doi:10.3389/fimmu.2014.00549. PMC 4217511. PMID 25404930.
- ↑ Sada KE, Amano K, Uehara R, Yamamura M, Arimura Y, Nakamura Y, Makino H (July 2014). "A nationwide survey on the epidemiology and clinical features of eosinophilic granulomatosis with polyangiitis (Churg-Strauss) in Japan". Mod Rheumatol. 24 (4): 640–4. doi:10.3109/14397595.2013.857582. PMID 24289197.